Clinical Trial Update: Improve PAD PERformance With METformin [Phase 3]

View source ↗

Summary

A Phase 3 trial sponsored by Northwestern University evaluated metformin for peripheral artery disease and has completed. This update reports the study status r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral Artery Disease

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Northwestern University | Conditions: Peripheral Artery Disease | Phase 3 | Status: COMPLETED